"10.1371_journal.pone.0091565","plos one","2014-03-24T00:00:00Z","Heiner K Berthold; Manfredi Rizzo; Nadine Spenrath; Giuseppe Montalto; Wilhelm Krone; Ioanna Gouni-Berthold","Department of Internal Medicine and Geriatrics, Bielefeld Evangelical Hospital (EvKB), Bielefeld, Germany; BioMedical Department of Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy; Euro-Mediterranean Institute of Science and Technology, Palermo, Italy; Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany","Conceived and designed the experiments: HKB MR IGB. Performed the experiments: HKB MR NS IGB. Analyzed the data: HKB MR IGB. Contributed reagents/materials/analysis tools: MR NS GM WK. Wrote the paper: HKB IGB. Revised the manuscript with important intellectual content: MR NS GM WK.","The authors have the following interests: The parent trial was supported in part by an investigator-initiated grant from MSD Sharp & Dohme. Dr. Berthold serves as an Academic Editor on the Editorial Board of PLOS ONE. Dr. Rizzo has given lectures, received honoraria or research support, and participated in conferences sponsored by AstraZeneca, Bracco, Bromatech, Chiesi Farmaceutici, Kowa, Novartis, Novo Nordisk, Rikrea and Servier. Dr. Krone has received grant/research support from MSD Sharp & Dohme and speakers honoraria from AstraZeneca, MSD Sharp & Dohme, Essex Pharma, Pfizer and Sanofi. Dr. Gouni-Berthold has received research grants from Bayer Health Care and honoraria and travel expenses from Genzyme, MSD Sharp & Dohme, Novartis, Novo Nordisk, Pfizer, Ipsen, Bristol Myers Squibb, Amgen, Sanofi and Otsuka. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","03","Heiner K Berthold","HKB",6,TRUE,3,4,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
